The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock
Clinical trial NCT04325035 · COMPLETED
Trial details
- NCT number
- NCT04325035
- Sponsor
- Windtree Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2024-09-26
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.